About 200 reports

‘Dementia with Diabetes—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Dementia with Diabetes epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Dementia with Diabetes Understanding Dementia is a...

  • Dementia
  • United States
  • United Kingdom
  • France
  • Japan
  • Germany
  • Spain
  • Italy
  • Dementia Prevalence

‘Dementia with Diabetes—Market Insights, Epidemiology and Market Forecast–2030’ report delivers an in-depth understanding of the Dementia with Diabetes, historical and forecasted epidemiology as well as the Dementia with Diabetes market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. The...

  • Dementia
  • Diabetes
  • United States
  • United Kingdom
  • Japan
  • Germany
  • France
  • Spain
  • Italy
  • Health Expenditure
  • Dementia Prevalence

The ongoing clinical trial research report- “2019 Vascular Dementias Ongoing Clinical Trials Study” analyzes the current scenario of all active Vascular Dementias trials across the world. The report presents top level analysis of global Vascular Dementias clinical trials across countries, companies and universities. It is designed to provide...

  • Clinical Trial
  • Dementia
  • World
  • APAC

The ongoing clinical trial research report- “2019 Dementia Associated With Alzheimer’s Disease Ongoing Clinical Trials Study” analyzes the current scenario of all active Dementia Associated With Alzheimer’s Disease trials across the world. The report presents top level analysis of global Dementia Associated With Alzheimer’s Disease clinical...

  • Dementia
  • Clinical Trial
  • World
  • APAC

Top Companies Participating in AIDS Associated Dementia Therapeutics Clinical Trials

  • Dementia
  • G7
  • APAC

Dementia Treatment Market - Overview This report analyzes the current and future scenario of the global dementia associated with Alzheimer’s disease market for the period 2018 to 2026. Rise in geriatric population, increased prevalence of Alzheimer’s, high unmet medical needs, and rich pipeline are likely to be major...

  • Dementia
  • World
  • Dementia Prevalence
  • Online Retail Sales

Global Psychiatry Partnering 2014 to 2021 provides the full collection of Psychiatry disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Psychiatry partnering deals Financial deal terms for headline, upfront and royalty by stage of development Psychiatry partnering...

  • Neurological Disorder
  • Anxiety Disorder
  • Dementia
  • Sleep Aid
  • Personality Disorder
  • World

“Dementia with Diabetes – Pipeline Insight, 2020,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Dementia with Diabetes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of...

  • Dementia
  • Diabetes
  • World
  • United States
  • Diabetes Prevalence

The global clinical trial report- “2019 Vascular Dementias Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Vascular Dementias. It presents in-depth analysis of Vascular Dementias clinical trials across markets and companies. The research work is for providing complete understanding into trends in...

  • Clinical Trial
  • Dementia
  • World

World Dementia Prevalence Dementia

  • Dementia
  • World
  • Dementia Prevalence
  • Elderly Population

EPIOMIC EPIDEMIOLOGY SERIES: FRONTOTEMPORAL LOBE DEMENTIA FORECAST IN ## MAJOR MARKETS 2018–2028

  • Dementia
  • Epidemiology
  • South Korea
  • Japan
  • Italy
  • India
  • Brazil
  • United Kingdom
  • Germany
  • China
  • Turkey
  • United States
  • Spain
  • Canada
  • France
  • Australia
  • Poland
  • Russia
  • Mexico
  • Argentina
  • Netherlands
  • Dementia Prevalence
  • Life Expectancy

“Vascular Dementia – Pipeline Insight, 2019” report outlays comprehensive insights of present scenario and growth prospects across Vascular Dementia. A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration...

  • Dementia
  • World

Lundbeck World Psychotic Disorder Depression Dementia Pharmaceutical Neurology

  • Drug Development
  • Dementia
  • Hormone
  • Pharmaceutical
  • World
  • Diagnostic Imaging Density

Major players in the Alzheimer’s disease treatment market are Allergan, Eisai Co. Ltd., Novartis AG, Pfizer Inc., Merz Pharma, H. Lundbeck A/S Biogen, AstraZeneca, and F. Hoffmann-La Roche Ltd. The global Alzheimer’s disease treatment market is expected to decline from $3.46 billion in 2019 to $3.42 billion in 2020 at a compound annual...

  • Dementia
  • World
  • United States
  • Dementia Incidence
  • Dementia Prevalence

“Dementia Associated With Alzheimer’s Disease – Pipeline Insight, 2019” report outlays comprehensive insights of present scenario and growth prospects across Dementia Associated With Alzheimer’s Disease. A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development...

  • Dementia
  • World

Figure ## Global Statistics of Dementia: 2015 and 2030 (Millions)

  • Dementia
  • World
  • Dementia Prevalence
  • Diagnostic Imaging Density

Small Molecules to Antagonize ##-HT ## and ##-HT##A for Behavioral and Psychological Symptoms of Dementia

  • Therapy
  • Drug Development
  • Dementia
  • Pharmaceutical
  • Hormone
  • Mental Health
  • World
  • Diagnostic Imaging Density
  • Drug Approval

"US Alzheimer’s Disease Drug Market, Dosage, Price & Clinical Trials Insight 2026" Report Highlights: • US Alzheimer’s Disease Drug Market Opportunity: > US$ 5 Billion • US Accounts For More Than 40% of Global Alzheimer’s Disease Drug Market • US Alzheimer’s Disease Drug Clinical Trials: 200 Drugs in Pipeline •...

  • Dementia
  • United States
  • Drug Approval

Indiana Dementia

  • Dementia
  • World
  • Toyama Prefecture
  • Indiana
  • Medicine Use
  • Cause-Specific Mortality Rate

World Dementia

  • Therapy
  • Dementia
  • World
  • Toyama Prefecture
  • Indiana
  • Cause-Specific Mortality Rate
  • Depression Prevalence

Dementia Associated With Alzheimer's Disease

  • Dementia
  • World

In January 2015, Pharmasum Therapeutics awarded up to NOK ## million grant from Norwegian Research Council for development of novel drugs for Alzheimer s disease and dementia.

  • Dementia
  • Therapy
  • World

Report Scope The scope of this report covers the global market for small molecule drugs, monoclonal antibodies, gene and cell therapies, and other biotechnology products that are approved or being developed for the treatment of neurological disorders. Therapeutic indications are grouped under four categories: cerebrovascular...

  • Neurological Disorder
  • Dementia
  • World
  • Cause-Specific Mortality Rate

Neurotrope Bioscience, Inc. World Neurological Disorder Dementia

  • Dementia
  • Neurological Disorder
  • World
  • Dropout Rate
  • Dementia Prevalence

Report Scope This research report presents an in-depth analysis of the global cognition and memory-enhancing drugs market by application, product categories, and regional markets.The report includes key cognition drugs that are incorporated in several therapeutic treatment methods. It discusses the role of supply...

  • Dementia
  • Research And Development
  • World
  • APAC

Small Molecules to Antagonize ##-HT ## and ##-HT##A for Behavioral and Psychological Symptoms of Dementia

  • Dementia
  • Pharmaceutical
  • Mental Health
  • Hormone
  • World
  • Diagnostic Imaging Density
  • Drug Approval

Dementia Associated With Alzheimer's Disease

  • Dementia
  • World
  • Diagnostic Imaging Density
  • Prescription Drug Sales

KEY FINDINGS The market of Alzheimer’s disease therapeutics and diagnostics of Europe is projected to register a CAGR of 5.42% over the projected period of 2020-2028. The rising geriatric population is one of the major factors driving the market growth in the region. MARKET INSIGHTS The European...

  • Healthcare
  • Diagnostics
  • Dementia
  • Europe
  • Health Expenditure
  • Elderly Population

Neurotrope Bioscience, Inc. World Neurological Disorder Dementia

  • Dementia
  • Neurological Disorder
  • World
  • Dropout Rate
  • Dementia Prevalence

Global Neurostimulation Devices Market to Reach $18,033.0 Million by 2030 Market Report Coverage - Neurostimulation Devices Market Segmentation • By Product Type: Implantable and non-implantable Implantable neurostimulation devices can be further segmented into seven types - spinal...

  • Therapy
  • Psychotic Disorder
  • Neurological Disorder
  • Analgesic
  • Dementia
  • World
  • Europe
  • North America